GW Henssler & Associates Ltd. lowered its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 17.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,363 shares of the medical equipment provider’s stock after selling 1,352 shares during the period. GW Henssler & Associates Ltd.’s holdings in Varian Medical Systems were worth $657,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of VAR. First Mercantile Trust Co. raised its stake in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 25 shares during the period. Parallel Advisors LLC raised its stake in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after buying an additional 176 shares during the period. Heritage Trust Co acquired a new stake in shares of Varian Medical Systems during the first quarter worth $118,000. Penserra Capital Management LLC raised its stake in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock worth $146,000 after buying an additional 140 shares during the period. Finally, Pacer Advisors Inc. raised its stake in shares of Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock worth $165,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 98.95% of the company’s stock.

Shares of Varian Medical Systems, Inc. (VAR) opened at 99.71 on Thursday. The company has a 50 day moving average price of $101.28 and a 200 day moving average price of $93.94. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.08. The company has a market cap of $9.15 billion, a P/E ratio of 32.82 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. During the same period in the prior year, the company posted $1.00 EPS. The company’s revenue was up 3.0% compared to the same quarter last year. Equities research analysts expect that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Varian Medical Systems, Inc. (VAR) Position Cut by GW Henssler & Associates Ltd.” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/17/varian-medical-systems-inc-var-position-cut-by-gw-henssler-associates-ltd.html.

A number of brokerages have weighed in on VAR. Off Wall Street began coverage on Varian Medical Systems in a research note on Monday, April 24th. They set a “sell” rating for the company. Robert W. Baird restated a “neutral” rating and set a $99.00 price objective (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. BidaskClub lowered Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Zacks Investment Research lowered Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Finally, Jefferies Group LLC restated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $96.28.

In other news, EVP Kolleen T. Kennedy sold 56,573 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $99.76, for a total value of $5,643,722.48. Following the sale, the executive vice president now directly owns 32,737 shares in the company, valued at approximately $3,265,843.12. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP John W. Kuo sold 734 shares of the company’s stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $101.91, for a total value of $74,801.94. Following the completion of the sale, the senior vice president now owns 28,095 shares in the company, valued at $2,863,161.45. The disclosure for this sale can be found here. Over the last quarter, insiders sold 159,372 shares of company stock worth $16,128,658. Corporate insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.